Question from Deputy Cathy Bennett - PQ 40025-26
Deputy Bennett asked about the reimbursement of risdiplam for adults living with spinal muscular atrophy (SMA). Read the HSE response.
- Published date:
- :
Browse and read HSE's latest publications, which include strategic plans, reports, official policies and codes, Parliamentary Question (PQ) responses, and board meeting minutes.
Deputy Bennett asked about the reimbursement of risdiplam for adults living with spinal muscular atrophy (SMA). Read the HSE response.
Deputy O'Sullivan asked about the impact of staffing shortages on service delivery across acute, community and home care services. Read the HSE response.
Deputy O'Flynn asked about assessment regarding legal, safeguarding or governance implications of overseas referrals involving minors. Read the HSE response.
Deputy Ó Muirí asked about an update on the planned extension of the Accident and Emergency Unit at Mayo University Hospital. Read the HSE response.
Deputy O'Flynn asked about whether the treatment abroad scheme is currently subject to any formal risk assessment. Read the HSE response.
Deputy O'Flynn asked about the reimbursement consideration for omaveloxolone (skyclarys). Read the HSE response.
Deputy McGuinness asked about the number of WTE consultant neurologists with a special interest in migraines and headaches based at UHW. Read the HSE response.
Deputy Crowe asked about the average waiting time for public patients referred by their GPs to see consultant dermatologists in each CHO. Read the HSE response.
Deputy O'Sullivan asked about monitoring and reporting mechanisms that exist under the Framework for Safe Nurse Staffing and Skill Mix. Read the HSE response.
Deputy Buckley asked about the eligibility to receive weight loss injections on the medical card. Read the HSE response.